Steve Harris has worked for U.S. auto manufacturers for the past 30 years as a research scientist, testing and investigating various promising materials and technologies. As a result, Harris knows a thing or two about what the industry values. Harris is now at the ALS as a visiting scientist, sharing his insight and knowledge with ALS staff scientists working on battery research. Their results could help drive the future of battery-powered transportation in this country.
Last year, drug discovery company Plexxikon made front-page news with its highly successful anti-cancer drug, Zelboraf, a product that was chemically optimized using data from ALS x-rays. Designed to disrupt malignant melanoma, the drug was so successful in human testing that trials were halted so that patients in the trial could all be given Zelboraf. Zelboraf marked a significant advancement for patients with metastatic melanoma who historically have had very limited treatment options.
ALS user Andrew McElrone’s research on grapevine rootstock water transport physiology is key to the future of California’s grape-growing industry. The plant biologist’s ultimate goal is to develop sustainable water use strategies for growers, giving them hard data about how much drought their plants can sustain and which species are ideal for an agricultural future with an uncertain water supply.